Amrutanjan Health Care Stock Screener | Share Price & Fundamental Analysis
AMRUTANJAN
Pharmaceuticals
Screen Amrutanjan Health Care share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹655.45
▼
-5.70 (-0.86%)
Share Price BSE
₹656.00
▼
-3.55 (-0.54%)
Market Cap
₹1,943.23 Cr.
P/B Ratio
5.64
EPS (TTM)
₹14.08
Dividend Yield
0.69%
Debt to Equity
0.02
52W High
₹767.65
52W Low
₹577.75
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹140.00
Total Equity
₹109.00
Amrutanjan Health Care Share Price History - Stock Screener Chart
Screen AMRUTANJAN historical share price movements with interactive charts. Analyze price trends and patterns.
Amrutanjan Health Care Company Profile - Fundamental Screener
Screen Amrutanjan Health Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMRUTANJAN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE098F01031
Amrutanjan Health Care Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AMRUTANJAN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2016 | 2015 |
|---|---|---|
| Assets | ||
| Total Assets | 140 | 124 |
| Current Assets | 101 | 83 |
| Fixed Assets | 29 | 24 |
| Liabilities | ||
| Total Liabilities | 140 | 124 |
| Current Liabilities | 4 | 3 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 109 | 95 |
| Share Capital | 3 | 3 |
| Reserves & Surplus | 106 | 92 |
Screen AMRUTANJAN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2016-March | 2015-March |
|---|---|---|---|
| Revenue | 0 | 192 | 171 |
| Expenses | 0 | 156 | 143 |
| EBITDA | 0 | 37 | 28 |
| Operating Profit % | 0.00% | 16.00% | 14.00% |
| Depreciation | 0 | 3 | 3 |
| Interest | 0 | 0 | 1 |
| Profit Before Tax | 0 | 32 | 24 |
| Tax | 0 | 12 | 9 |
| Net Profit | 0 | 21 | 15 |
| EPS | 0.00 | 14.08 | 10.31 |
Amrutanjan Health Care Cash Flow Screener - Liquidity Fundamentals
Screen AMRUTANJAN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2016-March | 2015-March |
|---|---|---|
| Operating Activities | 21 | 18 |
| Investing Activities | 4 | -5 |
| Financing Activities | -13 | -12 |
| Net Cash Flow | 12 | 2 |
Screen AMRUTANJAN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.52% | 46.52% | 46.52% | 50.59% | 50.59% | 46.52% | 46.52% | 50.04% |
| FII Holding | 2.30% | 2.41% | 2.38% | 1.38% | 1.55% | 2.34% | 2.30% | 0.00% |
| DII Holding | 11.41% | 12.70% | 12.90% | 7.29% | 7.32% | 10.60% | 11.12% | 7.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.56% | 32.28% | 32.18% | 34.17% | 33.87% | 34.09% | 33.73% | 35.38% |
| Other Holding | 6.22% | 6.09% | 6.02% | 6.57% | 6.67% | 6.45% | 6.33% | 7.41% |
| Shareholder Count | 51,674 | 49,431 | 47,954 | 62,664 | 57,169 | 54,536 | 53,856 | 69,947 |
Amrutanjan Health Care Dividend Screener - Share Yield Analysis
Screen AMRUTANJAN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹4.60 | 0.69% |
| 2024-March | ₹4.60 | 0.71% |
| 2023-March | ₹4.60 | 0.74% |
| 2022-March | ₹4.60 | 0.80% |
| 2021-March | ₹4.20 | 0.53% |
| 2020-March | ₹2.10 | 0.37% |
| 2019-March | ₹2.15 | 0.65% |
| 2018-March | ₹3.05 | 0.99% |
| 2017-March | ₹3.85 | 1.42% |
Amrutanjan Health Care Index Membership - Market Screener Classification
Screen AMRUTANJAN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Amrutanjan Health Care Market Events Screener - Corporate Actions
Screen AMRUTANJAN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.60 /share | 7.69% | ||
| Dividend | ₹ 2.60 /share | -8.04% | ||
| Annual General Meeting | NA | 15.67% | ||
| Dividend | ₹ 2.60 /share | 6.32% | ||
| Dividend | ₹ 2.60 /share | 4.98% | ||
| Annual General Meeting | NA | -2.94% | ||
| Annual General Meeting | NA | 5.89% | ||
| Dividend | ₹ 2.60 /share | -11.22% | ||
| Annual General Meeting | NA | -5.75% | ||
| 2025-11-18 | 2025-11-18 | Dividend | ₹ 1.00 /share | 0.36% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -1.32% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -4.43% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 5.45% |
| 2025-02-18 | 2025-02-18 | Dividend | ₹ 1.00 /share | -4.60% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.10% |
Amrutanjan Health Care Competitors Screener - Peer Comparison
Screen AMRUTANJAN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 414,629 | 39.37 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 169,515 | 67.76 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 131,253 | 60.85 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,957 | 22.30 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,604 | 18.24 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,293 | 22.10 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,151 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 90,569 | 50.34 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 70,521 | 20.25 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 66,359 | 27.11 | 13,458 | 3.70% | 2,216 | 38.49 |
Amrutanjan Health Care Company Announcements - News Screener
Screen AMRUTANJAN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-19 | Closure of Trading Window | View |
| 2025-11-11 | Investor Presentation For The Quarter Ended 30Th September 2025 | View |
| 2025-11-10 | Record Date For The First Interim Dividend Is 18 November 2025. | View |
| 2025-11-10 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-04 | Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Along With The Limited Review Report For The Quarter Ended 30Th September 2025 And Declaration Of The 1St Interim Dividend | View |
| 2025-10-18 | Disclosure Under Regulation 30 Of SEBI LODR 2015 | View |
| 2025-10-14 | Product Launch | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-23 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-15 | Monthly Update: Re-Lodgement Of Transfer Request Of Physical Shares | View |
| 2025-09-15 | Initmation Regarding Special Window For Relodgement Of Shares | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Corrigendum To Annual Report For The Financial Year 2024-2025 | View |
| 2025-08-29 | Business Responsibility and Sustainability Reporting (BRSR) | View |
| 2025-08-29 | Reg. 34 (1) Annual Report. | View |
| 2025-08-29 | 88Th Annual General Meeting Of The Company To Be Held On 23Rd September 2025. | View |